Pembrolizumab vs Strontium Chloride Sr 89

## Pembrolizumab vs Strontium Chloride Sr 89: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Strontium Chloride Sr 89**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Strontium Chloride Sr 89 — N/A.

## Chemical Properties

**Type**: Pembrolizumab — Antibody; Strontium Chloride Sr 89 — Small molecule.